Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

Abstract

<p>Supplementary Figure 3 displays baseline CM level by disease status at first restaging.</p>